Financial Performance - Total revenue for the first quarter was ¥663,377,866.71, a decrease of 18.77% compared to the previous year[23] - Net profit attributable to shareholders was -¥42,992,719.58, representing a decline of 421.28% year-on-year[23] - Total revenue for the current period is CNY 663,377,866.71, a decrease of 18.75% compared to CNY 816,698,365.88 in the previous period[35] - Operating revenue for the current period was $663.38 million, a decrease of 18.75% compared to $816.70 million in the previous period[51] - Net profit for the current period was a loss of $48.60 million, compared to a profit of $3.08 million in the previous period[51] - The total comprehensive income for the period was -48,680,637.99 RMB, a significant decrease from 2,585,604.80 RMB in the previous period[38] Cash Flow and Liquidity - Net cash flow from operating activities improved by 24.94%, amounting to -¥547,847,039.84[23] - Cash inflows from operating activities totaled 420,223,023.06 RMB, slightly up from 416,564,186.84 RMB in the previous period[38] - Cash flow from operating activities showed a net outflow of $547.85 million, an improvement from a net outflow of $729.89 million in the previous period[55] - Cash and cash equivalents at the end of the period increased to $2.21 billion, compared to $724.73 million at the end of the previous period[55] - The company maintains a stable cash position with no short-term borrowings reported[33] Assets and Liabilities - Total assets increased by 16.07% to ¥7,964,072,598.32 compared to the end of the previous year[23] - Total assets increased to CNY 7,964,072,598.32 from CNY 6,861,577,201.25, representing a growth of 16.06%[35] - Current liabilities decreased to CNY 4,055,928,649.03 from CNY 4,977,635,183.61, a reduction of 18.46%[35] - Long-term borrowings increased to CNY 622,875,240.74 from CNY 498,350,000.00, showing a rise of 25.00%[35] - Non-current liabilities rose to CNY 772,920,408.99 from CNY 655,283,612.88, an increase of 17.93%[35] Shareholder Information - Shareholders' equity attributable to the parent company rose by 150.56% to ¥3,181,296,589.08[23] - The total number of restricted shares held by the top 10 preferred shareholders amounts to 2,540,115 shares, all of which remain restricted as of the end of the reporting period[31] - The total number of restricted shares increased by 255,607,229 shares during the reporting period, bringing the total to 259,974,889 shares[33] - The number of ordinary shareholders at the end of the reporting period was 49,288[29] Income and Expenses - Investment income increased by 577.61% year-on-year, primarily due to higher returns from joint ventures and associates[26] - Non-operating income from government subsidies was ¥9,820,133.10, while other non-operating income and expenses totaled -¥522,056.60[8] - The company experienced a 41.95% year-on-year decrease in other income, mainly due to a decline in government subsidies received[10] - Total operating costs decreased to $722.55 million, down 12.43% from $825.11 million in the previous period[51] - Research and development expenses increased to $99.43 million, up 17.00% from $85.02 million in the previous period[51] - Tax expenses decreased to $1.37 million from $2.80 million in the previous period[51] - The company experienced a decrease in sales expenses to $34.99 million, down 23.19% from $45.58 million in the previous period[51] Other Financial Metrics - Cash paid for goods and services was 512,376,038.44 RMB, an increase from 491,210,570.56 RMB in the previous period[38] - Cash paid to employees was 364,193,731.32 RMB, down from 543,700,907.38 RMB in the previous period[38] - The net increase in cash from operating activities was impacted by a decrease in comprehensive income and cash outflows for employee payments[38] - The company reported a foreign currency translation loss of -80,857.25 RMB, compared to -493,827.99 RMB in the previous period[38] - The company did not report any significant changes in investment or financing activities during the period[38] - There were no new product launches or technological advancements mentioned in the report[38]

Health Management Services - The company is a leader in the health management market, with increasing demand for health management services, particularly in mid-term and long-term stability [21]. - The company’s health management services are increasingly standardized and transparent, with a focus on technological, quality, and quantitative improvements in product offerings [21]. - The company’s innovative health management services aim to meet diverse health needs through personalized and multi-faceted approaches [9]. - The user base of the company's health management app reached 4.98 million, an increase of 23.6% compared to the previous year [85]. - The user base of the Man Niu Health APP reached 470,000, reflecting stable growth in the health management sector [96]. - The company has signed contracts with nearly 40 public hospital health check centers, establishing a nationwide quality medical resource service network [84]. Digital Transformation and Smart City Initiatives - The company focuses on building a digital infrastructure based on 5G networks, cloud computing, and big data, providing solutions for smart healthcare and smart governance [15]. - The company is involved in the development of smart city initiatives, which are strategically important for urban sustainable development and digital transformation [17]. - The company is leveraging national policies to enhance the construction of smart cities and digital government services, aiming to improve urban governance efficiency [18]. - The company has established a city-level data hub to support comprehensive data collection, integration, and governance, promoting a data-driven urban management framework [44]. - The company is currently developing a smart city service platform aimed at enhancing community governance and integrating public data, with a focus on utilizing cloud computing, big data, IoT, and AI technologies [177]. - The company aims to establish a community ecosystem service platform through the smart city project, which is expected to expand its market presence [177]. Financial Performance and Revenue - In 2022, the company achieved operating revenue of 3.224 billion yuan, a year-on-year decrease of 8.24%, and a net profit attributable to shareholders of -290 million yuan [119]. - Total operating revenue for 2022 was 3,223,537,007.67 yuan, representing a decrease of 8.24% compared to 2021 [123]. - Revenue from the smart healthcare sector was 1,567,460,465.61 yuan, accounting for 48.62% of total revenue, with a slight decrease of 0.14% year-on-year [123]. - The smart government sector's revenue decreased by 24.94% year-on-year to 1,149,484,239.64 yuan, representing 35.66% of total revenue [123]. - The company reported a gross margin of 51.61% on signed contracts, an increase of 3.46 percentage points year-on-year [126]. - The company’s innovative business grew by 28.97% year-on-year, contributing 15.68% to total revenue, with a revenue increase of 23.01% [127]. Research and Development - The company has strengthened its investment in research and development for industry-specific solutions, particularly in the fields of government and healthcare [53]. - R&D investment amounted to CNY 504,527,141.86 in 2022, representing 15.65% of operating revenue, up from 12.76% in 2021 [142]. - The company has participated in over 10 national key research and development projects, enhancing its product capabilities in areas such as data processing and intelligent services [101]. - The company accumulated over 400 independent intellectual property rights during the reporting period, with a total of more than 2,700 rights held [100]. - The company completed the development of the new generation smart healthcare integrated HIS service platform, which is expected to enhance market competitiveness [139]. Challenges and Operational Issues - The company has faced challenges in project implementation and client acceptance, impacting revenue recognition and overall profitability [119]. - The company reported significant differences between cash flow from operating activities and net profit for the year, indicating potential operational challenges [181]. - The company has not reported any significant changes in project feasibility or reasons for not meeting expected benefits [189]. Strategic Partnerships and Collaborations - The company has established strategic partnerships with multiple ecological partners to enhance health management services, achieving stable revenue from specialized services in collaboration with renowned hospitals [58]. - The company is collaborating with major banks to expand its government service projects, enhancing its capabilities in public administration [37]. Market Expansion and Presence - The company has maintained good momentum in expanding its market presence in regions such as the Yangtze River Delta, Southwest, Central South, and Northwest [15]. - The company signed significant contracts in regions such as Anhui, Henan, and Xinjiang, enhancing its market presence [126]. Technology and Innovation - The company is actively expanding its ICT business, leveraging innovations in cloud computing, big data, and artificial intelligence to drive digital transformation for clients [39]. - The company continues to innovate by integrating emerging technologies such as cloud computing, big data, and blockchain into its solutions for smart cities [101]. - Wanda Information's products and solutions in big data, AI pathology, and digital operations are tailored to meet the demands of various sectors, enhancing service efficiency [94]. Awards and Recognition - The company has received multiple awards, including the "Annual Excellent Medical Health Innovation Award" at the InsurStar Insurance Technology Industry Awards [96]. - Wanda Information is recognized as a national technology innovation demonstration enterprise, emphasizing its commitment to technological advancement in smart cities and health management [100].

出席本次年度业绩说明会的人员有： 5、 保荐代表人敬启志先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 4 月 27 日（星期四）13:00 前访问 http://ir.p5w.net/zj/，或扫描下方二维码，进入 问题征集专题页面。公司将在 2022 年度业绩说明会上，对投资者普遍关注的问 题进行回答。 欢迎广大投资者积极参与本次网上说明会！ 1 1、 副董事长、总裁胡宏伟先生； 2、 独立董事刘功润先生； 3、 高级副总裁、财务总监陈丽娜女士； 4、 高级副总裁、董事会秘书张丽艳女士； 证券代码：300168 证券简称：万达信息 公告编号：2023-024 万达信息股份有限公司 关于举行 2022 年度业绩网上说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 万达信息股份有限公司（以下简称"公司"、"万达信息"）《2022 年年度报 告》于 2023 年 4 月 25 日披露。为方便投资者进一步了解公司经营情况，公司定 于 2023 ...

投资者关系活动档案 万达信息股份有限公司 投资者关系活动 | --- | --- | |-----------|----------------------------------------------------------------------------------------------------------------------------------------| | | | | 名称 | 万达信息股份有限公司机构投资者调研会（电话会议形式） | | 时间 | 2015 年 8 月 7 日（星期五） | | 地点 | 申万宏源 | | | 万达信息副总裁兼财务负责人 王清 | | | 申万宏源计算机团队 | | | 刘洋 18930809428 | | 参与 人员 | 刘智 18916570616 刘畅 18516123788 孙家旭 15000718980 刘高畅 13920105213 | | | | | 过程 | 机构投资者就公司中标"中国非公立医疗行业信息化服务管理平台"相 关问题进行提问，公司副总裁兼财务负责人王清一一进行了电话沟通， 纪要如下： | | 内容、 | 基本情况 万 ...

Group 1: Major Restructuring Plan - The company established Shanghai Jiada Information Technology Co., Ltd. with Jia Shi Investment Management Co., Ltd. to handle external mergers and support healthcare operations in Sichuan [1] - Jiada Information holds less than 1% of shares, primarily as an investment company [1] - The restructuring plan is more financially advantageous compared to previous private placement proposals [1] Group 2: Interactive Q&A Insights - The company opted not to pursue a new private placement due to market volatility affecting the previous plan, instead focusing on establishing an investment company [3] - The acquisition of three companies is closely aligned with the company's existing business, enhancing the synergy around healthcare services [3] - The company acquired 45% equity in a health cloud service, which requires additional funding for further development [4] Group 3: Business Model and Future Projections - The company anticipates a shift towards a mixed model of B2B and B2C services, with a target of reaching 10 million users by 2016 [7] - In 2015, the health service covered 4-5 million people, with active users around several tens of thousands [7] - The company expects stable growth in its main business for the next 5-6 years, focusing on innovation and transparency [8] Group 4: Data and Technology Utilization - The company has a comprehensive health data database in Ningbo, covering over 1 million people, which is utilized for various research projects [5] - The company is transitioning from traditional IT software development to a SaaS model, with 99% of current revenue still from software and services [6] - The company is developing a B2B procurement platform that connects all hospitals and pharmacies in Shanghai, with transaction volumes reaching hundreds of billions [10]

投资者关系活动档案 万达信息股份有限公司 投资者关系活动 | --- | --- | |-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...